Neuro-Oncology Reviews
Volume
25 Number 16
31 August 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 16, 31 August
Bianconi A, Bonada M, Zeppa P,
Colonna S, Tartara F, Melcarne A, Garbossa D, Cofano F.
How
Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A
Systematic Review Concerning Different Fluorophores.
Cancers
(Basel). 2023 Aug 16;15(16):4130∟.
doi: 10.3390/cancers15164130∟.
PMID: 37627158∟.
Review. ˍ
Eliyasi Dashtaki M, Moradi Z,
Moradi Y, Asadi E, Ghasemi S.
Estimating
the survival rate in glioblastoma multiforme patients who received
a peptide vaccine: a systematic review and meta-analysis.
Curr
Drug Targets. 2023 Aug 16∟.
doi: 10.2174/1389450124666230816114131∟.
PMID: 37587807∟.
Review, Meta-analysis˰ ˍ
Nafe R, Hattingen E.
The
Spectrum of Molecular Pathways in Gliomas-An Up-to-Date
Review.
Biomedicines.
2023 Aug 16;11(8):2281∟.
doi: 10.3390/biomedicines11082281∟.
PMID: 37626776∟.
Review. ˍ
Schladerer SP, Otth M, Scheinemann
K.
Quality
criteria for pediatric oncology centers: A systematic literature
review.
Cancer
Med. 2023 Aug 16∟.
doi: 10.1002/cam4.6452∟.
PMID: 37584279∟.
Review. ˍ
Askari FS, Mohebbi A, Ning J,
Kurozumi K, Wakimoto H.
Editorial:
Recent advances in oncolytic virus therapy for brain tumors.
Front
Cell Infect Microbiol. 2023 Aug 17;13:1271559∟.
doi: 10.3389/fcimb.2023.1271559∟.
PMID: 37662010∟.
Editorial. ˍ
Endersby R, Wainwright BJ, Gottardo
NG.
Editorial:
Bench to bedside: translating pre-clinical research into clinical
trials for childhood brain tumors.
Front
Oncol. 2023 Aug 17;13:1274465∟.
doi: 10.3389/fonc.2023.1274465∟.
PMID: 37664044∟.
Editorial. ˍ
Guarnera A, Romano A, Moltoni G,
Ius T, Palizzi S, Romano A, Bagatto D, Minniti G, Bozzao A.
The
Role of Advanced MRI Sequences in the Diagnosis and Follow-Up of
Adult Brainstem Gliomas: A Neuroradiological Review.
Tomography.
2023 Aug 18;9(4):1526-1537∟.
doi: 10.3390/tomography9040122∟.
PMID: 37624115∟.
Review. ˍ
Hooper GW, Ansari S, Johnson JM,
Ginat DT.
Advances
in the Radiological Evaluation of and Theranostics for
Glioblastoma.
Cancers
(Basel). 2023 Aug 18;15(16):4162∟.
doi: 10.3390/cancers15164162∟.
PMID: 37627190∟.
Review. ˍ
Sahoo DK, Mishra S, Mohanty MN,
Behera RK, Dhar SK.
Brain
Tumor Detection using Deep Learning Approach.
Neurol
India. 2023 Aug 18;71(4):647-654∟.
doi: 10.4103/0028-3886.383858∟.
PMID: 37635491∟.
Review. ˍ
*
Segar DJ, Bernstock JD, Rampersad
S, Linda Bi W, Arnaout O, Friedman GK, Chiocca EA.
Intracranial
stimulation for brain cancer-The case for implantable,
intracranial tumor treating fields.
Neurooncol
Adv. 2023 Aug 19;5(1):vdad100∟.
doi: 10.1093/noajnl/vdad100∟.
PMID: 37706199∟.
Review. ˍ
Tang F, Wang Y, Zeng Y, Xiao A,
Tong A, Xu J.
Tumor-associated
macrophage-related strategies for glioma immunotherapy.
NPJ
Precis Oncol. 2023 Aug 19;7(1):78∟.
doi: 10.1038/s41698-023-00431-7∟.
PMID: 37598273∟.
Review. ˍ
Hasanzadeh A, Moghaddam HS, Shakiba
M, Jalali AH, Firouznia K.
The
Role of Multimodal Imaging in Differentiating Vasogenic from
Infiltrative Edema: A Systematic Review.
Indian
J Radiol Imaging. 2023 Aug 21;33(4):514-521∟.
doi: 10.1055/s-0043-1772466∟.
PMID: 37811185∟.
Review. ˍ
Hu Y, Li Z, Zhang Y, Wu Y, Liu Z,
Zeng J, Hao Z, Li J, Ren J, Yao M.
The
Evolution of Tumor Microenvironment in Gliomas and Its Implication
for Target Therapy.
Int
J Biol Sci. 2023 Aug 21;19(13):4311-4326∟.
doi: 10.7150/ijbs.83531∟.
PMID: 37705736∟.
Review. ˍ
Huisman TAGM, Patel R, Kralik S,
Desai NK, Meoded A, Chen K, Weiner HL, Curry DJ, Lequin M,
Kranendonk M, Orman G, Jallo G.
Advances
in Imaging Modalities for Pediatric Brain and Spinal Cord
Tumors.
Pediatr
Neurosurg. 2023 Aug 21∟.
doi: 10.1159/000531998? PMID: 37604135∟.
Review. ˍ
*
Yuan Y, Su Y, Wu Y, Xue Y, Zhang Y,
Zhang Y, Zheng M, Chang T, Qu Y, Zhao T.
Knowledge
structure and hotspots research of glioma immunotherapy: a
bibliometric analysis.
Front
Oncol. 2023 Aug 21;13:1229905∟.
doi: 10.3389/fonc.2023.1229905∟.
PMID: 37671057∟.
Bibliometric analysis. ˍ
Bérard C, Truillet C, Larrat
B, Dhermain F, Estève MA, Correard F, Novell A.
Anticancer
drug delivery by focused ultrasound-mediated blood-brain/tumor
barrier disruption for glioma therapy: From benchside to
bedside.
Pharmacol
Ther. 2023 Aug 22;250:108518∟.
doi: 10.1016/j.pharmthera.2023.108518∟.
PMID: 37619931∟.
Review˰ ˍ
Ismail M, Craig S, Ahmed R, de
Blank P, Tiwari P.
Opportunities
and Advances in Radiomics and Radiogenomics for Pediatric
Medulloblastoma Tumors.
Diagnostics
(Basel). 2023 Aug 22;13(17):2727∟.
doi: 10.3390/diagnostics13172727∟.
PMID: 37685265∟.
Review. ˍ
Lee J, Chen MM, Liu HL, Ucisik FE, Wintermark M, Kumar VA.
MR
Perfusion Imaging for Gliomas.
Magn Reson Imaging Clin
N Am. 2023 Aug 22, 2024;32(1):73-83∟.
doi: 10.1016/j.mric.2023.07.003∟.
PMID: 38007284∟.
Review˰ ˍ
*
Wang XC, Tang YL, Liang XH.
Tumour
follower cells: A novel driver of leader cells in collective
invasion (Review).
Int
J Oncol. 2023 Aug 22;63(4):115∟.
doi: 10.3892/ijo.2023.5563∟.
PMID: 37615176∟.
Review. ˍ
Ren CC, Xu B, Wang MS, He F, Chen
JH, Liao L, Liang W.
Meta-analysis
of the correlation between glioma prognosis and PD-1/PD-L1
expression.
Asian
J Surg. 2023 Aug 23:S1015-9584(23)01225-3∟.
doi: 10.1016/j.asjsur.2023.08.057∟.
PMID: 37625958∟.
Meta-analysis. ˍ
Todeschi J, Dannhoff G, Chibbaro S, Segbedji F, Spatola G,
Mallereau CH, Noel G, Schott R, Lhermitte B, Cebula H, Ganau
M.
Second Cancer affecting the Central
Nervous System: Systematic Literature Review Exploring the Link
between Malignant Melanoma and Glioblastoma.
World
Neurosurg. 2023 Aug 23:S1878-8750(23)01185-3∟.
doi: 10.1016/j.wneu.2023.08.073∟.
PMID: 37625631∟.
Review˰ ˍ
Papadopoulou A, Kumar
NS.
Prognostic
Factors and Resectability Predictors in Insular Gliomas: A
Systematic Review.
J
Neurol Surg A Cent Eur Neurosurg. 2023 Aug 24∟.
doi: 10.1055/s-0043-1769128∟.
PMID: 37619597∟.
Review. ˍ
Skouras P, Markouli M, Kalamatianos
T, Stranjalis G, Korkolopoulou P, Piperi C.
Advances
on Liquid Biopsy Analysis for Glioma Diagnosis.
Biomedicines.
2023 Aug 24;11(9):2371∟.
doi: 10.3390/biomedicines11092371∟.
PMID: 37760812∟.
Review. ˍ
Sleurs C, Fletcher P, Mallucci C,
Avula S, Ajithkumar T.
Neurocognitive
Dysfunction After Treatment for Pediatric Brain Tumors:
Subtype-Specific Findings and Proposal for Brain Network-Informed
Evaluations.
Neurosci
Bull. 2023 Aug 24∟.
doi: 10.1007/s12264-023-01096-9∟.
PMID: 37615933∟.
Review. ˍ
Veikutis V, Brazdziunas M, Keleras
E, Basevicius A, Grib A, Skaudickas D, Lukosevicius S.
Diagnostic
Approaches to Adult-Type Diffuse Glial Tumors: Comparative
Literature and Clinical Practice Study.
Curr
Oncol. 2023 Aug 24;30(9):7818-7835∟.
doi: 10.3390/curroncol30090568∟.
PMID: 37754483∟.
Review, Observational study. ˍ
Ahmed SK, Keole SR.
Proton
Therapy in the Adolescent and Young Adult Population.
Cancers
(Basel). 2023 Aug 25;15(17):4269∟.
doi: 10.3390/cancers15174269∟.
PMID: 37686545∟.
Review. ˍ
Bozzao A, Weber D, Crompton S, Braz
G, Csaba D, Dhermain F, Finocchiaro G, Flannery T, Kramm C, Law I,
Marucci G, Oliver K, Ostgathe C, Paterra R, Pesce G, Smits M,
Soffietti R, Terkola R, Watts C, Costa A, Poortmans P.
European
Cancer Organisation Essential Requirements for Quality Cancer
Care: adult glioma.
J
Cancer Policy. 2023 Aug 25:100438∟.
doi: 10.1016/j.jcpo.2023.100438∟.
PMID: 37634617∟.
Editorial˰ ˍ
De Pietro R, Zaccaro L, Marampon F,
Tini P, De Felice F, Minniti G.
The
evolving role of reirradiation in the management of recurrent
brain tumors.
J
Neurooncol. 2023 Aug 25∟.
doi: 10.1007/s11060-023-04407-2∟.
PMID: 37624529∟.
Review. ˍ
Qureshi HM, Tabor JK, Pickens K,
Lei H, Vasandani S, Jalal MI, Vetsa S, Elsamadicy A, Marianayagam
N, Theriault BC, Fulbright RK, Qin R, Yan J, Jin L, O'Brien J,
Morales-Valero SF, Moliterno J.
Frailty
and postoperative outcomes in brain tumor patients: a systematic
review subdivided by tumor etiology.
J
Neurooncol. 2023 Aug 25∟.
doi: 10.1007/s11060-023-04416-1∟.
PMID: 37624530∟.
Review. ˍ
Reddy R, Yan SC, Hasanpour
Segherlou Z, Hosseini-Siyanaki MR, Poe J, Perez-Vega C, Chiocca
EA, Lucke-Wold B.
Oncolytic
viral therapy: a review and promising future directions.
J
Neurosurg. 2023 Aug 25:1-9∟.
doi: 10.3171/2023.6.JNS23243∟.
PMID: 37877961∟.
Review˰ ˍ
Gonçalves TL, de Araújo
LP, Pereira Ferrer V.
Tamoxifen
as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast
cancer and glioblastoma view.
Cytokine.
2023 Aug 26;170:156344∟.
doi: 10.1016/j.cyto.2023.156344∟.
PMID: 37639844∟.
Review˰ ˍ
Vaz-Salgado MA, Villamayor M,
Albarrán V, Alía V, Sotoca P, Chamorro J, Rosero D,
Barrill AM, Martín M, Fernandez E, Gutierrez JA,
Rojas-Medina LM, Ley L.
Recurrent
Glioblastoma: A Review of the Treatment Options.
Cancers
(Basel). 2023 Aug 26;15(17):4279∟.
doi: 10.3390/cancers15174279∟.
PMID: 37686553∟.
Review. ˍ
Bagchi A, Dhanda SK, Dunphy P,
Sioson E, Robinson GW.
Molecular
Classification Improves Therapeutic Options for Infants and Young
Children With Medulloblastoma.
J
Natl Compr Canc Netw. 2023 Aug 28:1-9∟.
doi: 10.6004/jnccn.2023.7024∟.
PMID: 37643637∟.
Review. ˍ
Tao JC, Yu D, Shao W, Zhou DR, Wang
Y, Hou SQ, Deng K, Lin N.
Interactions
between microglia and glioma in tumor microenvironment.
Front
Oncol. 2023 Aug 28;13:1236268∟.
doi: 10.3389/fonc.2023.1236268∟.
PMID: 37700840∟.
Review. ˍ
Liu X, Zhao Z, Dai W, Liao K, Sun
Q, Chen D, Pan X, Feng L, Ding Y, Wei S.
The
Development of Immunotherapy for the Treatment of Recurrent
Glioblastoma.
Cancers
(Basel). 2023 Aug 29;15(17):4308∟.
doi: 10.3390/cancers15174308∟.
PMID: 37686584∟.
Review. ˍ
Patiño-García A,
Alonso MM, Gállego Pérez-Larraya J.
Promises
of oncolytic viral therapy for adult and children with brain
glioma.
Curr
Opin Oncol. 2023 Aug 29;35(6):529-535∟.
doi: 10.1097/CCO.0000000000000995∟.
PMID: 37820087∟.
Review˰ ˍ
Roque D, Cruz N, Ferreira HA, Reis
CP, Matela N, Herculano-Carvalho M, Cascão R, Faria
CC.
Nanoparticle-Based
Treatment in Glioblastoma.
J
Pers Med. 2023 Aug 29;13(9):1328∟.
doi: 10.3390/jpm13091328∟.
PMID: 37763096∟.
Review. ˍ
Ale Y, Nainwal N.
Progress
and Challenges in the Diagnosis and Treatment of Brain Cancer
Using Nanotechnology.
Mol
Pharm. 2023 Aug 30∟.
doi: 10.1021/acs.molpharmaceut.3c00554∟.
PMID: 37647568∟.
Review˰ ˍ
de Ruiter Swain J, Michalopoulou E,
Noch EK, Lukey MJ, Van Aelst L.
Metabolic
partitioning in the brain and its hijacking by glioblastoma.
Genes
Dev. 2023 Aug 30∟.
doi: 10.1101/gad.350693.123∟.
PMID: 37648371∟.
Review˰ ˍ
Perez Giraldo GS, Singer L, Cao T,
Jamshidi P, Dixit K, Kontzialis M, Castellani R, Pytel P, Anadani
N, Bevan CJ, Grebenciucova E, Balabanov R, Cohen BA, Graham
EL.
Differential
Diagnosis of Tumor-like Brain Lesions.
Neurol
Clin Pract. 2023 Aug 30;13(5):e200182∟.
doi: 10.1212/CPJ.0000000000200182∟.
PMID: 37664132∟.
Review˰ ˍ
Pires HFO, da Silva PR, Dias AL, de
Sousa Gomes C, de Sousa NF, Dos Santos AMF, Souza LRP, de
Figueiredo Lima JL, Oliveira MCN, Felipe CFB, de Almeida RN, de
Castro RD, da Silva Stiebbe Salvadori MG, Scotti MT, Scotti
L.
Mechanisms
Involved in the Therapeutic Effect of Cannabinoid Compounds on
Gliomas: A Review with Experimental Approach.
Curr
Protein Pept Sci. 2023 Aug 30∟.
doi: 10.2174/1389203724666230830125423∟.
PMID: 37649287∟.
Review˰ ˍ
Smolarska A, Pruszynska I, Wasylko
W, Godlewska K, Markowska M, Rybak A, Botther J, Kucharzewska P,
Nowakowska J, Szeliga J, Kubiak M, Gorczak M, Krol M.
Targeted
therapies for glioblastoma treatment.
J
Physiol Pharmacol. 2023 Aug 30;74(3)∟.
doi: 10.26402/jpp.2023.3.01? PMID: 37661178∟.
Review˰ ˍ
Serritella AV, Shenoy NK.
Nivolumab
Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than
Melanoma: A Meta-Analysis.
JAMA
Oncol. 2023 Aug 31:e233295∟.
doi: 10.1001/jamaoncol.2023.3295∟.
PMID: 37651124∟.
Meta-analysis. ˍ
Tinnirello R, Chinnici CM, Miceli
V, Busà R, Bulati M, Gallo A, Zito G, Conaldi PG, Iannolo
G.
Two
Sides of The Same Coin: Normal and Tumoral Stem Cells, The
Relevance of In Vitro Models and Therapeutic Approaches: The
Experience with Zika Virus in Nervous System Development and
Glioblastoma Treatment.
Int
J Mol Sci. 2023 Aug 31;24(17):13550∟.
doi: 10.3390/ijms241713550∟.
PMID: 37686355∟.
Review. ˍ